Endurant Capital Management LP Bristol Myers Squibb CO Transaction History

Endurant Capital Management LP

$0
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $20,633 - $12.2 Million	158,721 New	158,721 $11.3 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $14.1 Million - $15.6 Million	-194,684 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $12 Million - $14.4 Million	194,684 New	194,684 $14.2 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $11.4 Million - $13.2 Million	-211,821 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $6.55 Million - $7.68 Million	110,740 Added 109.56%	211,821 $12.5 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $8.22 Million - $8.95 Million	-132,817 Reduced 56.78%	101,081 $6.75 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $603,369 - $678,612	-10,168 Reduced 4.17%	233,898 $14.8 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $8.44 Million - $9.56 Million	-146,090 Reduced 37.44%	244,066 $15.1 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $20.3 Million - $22.5 Million	354,047 Added 980.5%	390,156 $23.5 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $5.53 Million - $6.46 Million	-100,816 Reduced 73.63%	36,109 $2.12 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $12.3 Million - $17.8 Million	-264,509 Reduced 65.89%	136,925 $7.63 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $5.39 Million - $7.03 Million	109,509 Added 37.51%	401,434 $25.8 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $8.79 Million - $10.4 Million	205,628 Added 238.28%	291,925 $14.8 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $9.15 Million - $10.1 Million	-204,984 Reduced 70.37%	86,297 $3.91 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $10.9 Million - $13 Million	241,944 Added 490.39%	291,281 $13.9 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $1.4 Million - $1.81 Million	-28,634 Reduced 36.72%	49,337 $2.57 Million
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $4.3 Million - $4.85 Million	77,971 New	77,971 $4.84 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.32 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.46 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.58 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.58 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Account